The FDA plan would let pharmacies compound peptides like BPC-157 under enforcement discretion, even though agency scientists say safety is unproven.
Recap by typeshit. Full story at Newsradio 600 KOGO.
A man says Mounjaro and Trulicity caused his gastroparesis, and the clip walks through who must warn patients about side effects under Indiana law.
Alicia Butterfield claims Anthem denied her Zepbound once the drug got her below morbid obesity. A Los Angeles judge stayed her case pending arbitration.
STAT
Members of Congress from both parties want the FDA to stop imports of copycat versions of Eli Lilly's experimental obesity drug, which is still in trials.
Health Secretary Robert F. Kennedy Jr. said Tuesday the goal is to widen access to peptides through a regulated marketplace, Reuters reports.
Le Figaro reports the tablet arrives in early November. Unlike the Wegovy injection, it won't be covered by France's public reimbursement system.
A short post from the endocrinologist pushing back on headlines tying the eye condition to GLP-1 drugs, urging people to look at the data.
Loading…